Delivery Order SPE2DB20D3303-SPE2DB24FA0ZY
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,260.68 firm fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes. The award has an ultimate completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $34,232.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Firm Fixed Price contract, which has an ultimate completion date of December 20, 2024, is for the delivery of 4566771042 - PROLIA 60 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award, with a ceiling value of $3,572.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Prolia 60 mg/ml syringes, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a performance period ending on May 7, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $31,449.70. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to provide PROLIA 60 MG/ML SYRINGEML. The contract has an ultimate completion date of January 27, 2025 and does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,743.42 firm-fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes, with a period of performance through September 2024. Amerisourcebergen is delivering these pharmaceutical products under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,142.90 firm fixed-price delivery order is for the supply of PROLIA 60 MG/ML SYRINGE medical products. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Prolia 60 mg/ml syringes. The contract has a ceiling value of $8,828.08 and is a firm fixed-price, non-set-aside contract with a performance period through May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,619.06 delivery order contract is for the supply of Prolia 60 mg/ml syringes, a medication used to treat osteoporosis. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price Delivery Order contract worth $3,486.84 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Prolia 60 mg/mL syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,409.04 firm fixed-price delivery order is for Prolia 60 mg/ml syringes, a specialty medication used in the treatment of certain medical conditions. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...